Elan Tye is a Principal with JAZZ Venture Partners focused on technologies that unlock human potential, particularly in healthcare. JAZZ is a mid-sized traditional venture capital firm typically leading or co-leading late seed through series B rounds. Previously Elan founded and grew several startups as an operator and adviser across digital health, neuroscience, and AI, including co-founding Swing Therapeutics and Blue Note Therapeutics. Other past experiences include the Boston Consulting Group and Monitor Deloitte, where he incubated startups and advised executives. He received his bachelor’s degree from Tufts University and his MBA from the University of California, Berkeley.